Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Conditioning Regimens

Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure

Bone Marrow Transplantation volume 32, pages 869–872 (2003)Cite this article

Summary:

Allogeneic stem cell transplantation (allo-SCT) after a reduced-intensity conditioning (RIC) protocol is associated with decreased short-term toxicity. This suggests that the procedure could be performed on an outpatient basis. We analysed the incidence and risk factors of grade ⩾2 conditioning-related toxicities (CRTs) as a hallmark for hospital admission, in 41 consecutive patients allografted from an HLA identical sibling after RIC. The RIC regimen consisted of fludarabine plus melphalan for lymphoid malignancies, and fludarabine plus busulphan for myeloid malignancies. In all, 11 patients (27%) did not experience any toxicity. The more frequent CRTs observed were neutropenic fever and gastrointestinal toxicity. The median duration of hospitalisation was 27 (range, 17–50) days. If allo-SCT had been planned as an outpatient procedure and admission indicated only in the case of ⩾2 CRTs, the inpatient period would have decreased to 9 (range, 0–33) days (P<0.001). No risk factors for CRTs were identified. Allo-SCT after an RIC regimen is a well-tolerated procedure. Our results warrant a prospective pilot trial of nonmyeloablative allo-SCT performed in the outpatient setting.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Barret J, Childs R . Non-myeloablative stem cell transplants. Br J Haematol 2000; 111: 6–17.

    Article  Google Scholar 

  2. Carella AM, Giralt S, Slavin S . Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia. Haematologica 2000; 85: 304–313.

    CAS  PubMed  Google Scholar 

  3. Champlin R, Khouri L, Komblau S et al. Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative preparative regimens and induction of graft-versus-malignancy. Curr Opin Oncol 1999; 11: 87–95.

    Article  CAS  PubMed  Google Scholar 

  4. McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumour effects. Blood 2001; 97: 3390–4000.

    Article  CAS  PubMed  Google Scholar 

  5. Weissinger F, Sandmaier BM, Maloney DG et al. Decreased transfusion requirements for patients receiving nonmyelo-ablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood 2001; 98: 3584–3588.

    Article  CAS  PubMed  Google Scholar 

  6. Miler AB, Hoogstraten B, Syaquet M, Winkler A . Reporting results of cancer treatment. Cancer 1981; 47: 207–214.

    Article  Google Scholar 

  7. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 12–20.

    Google Scholar 

  8. Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using a fludarabine-based nonablative chemotherapy and allogeneic blood progenitor transplantation as treatment for lymphoid malignancy. J Clin Oncol 1998; 8: 2817–2824.

    Article  Google Scholar 

  9. Schetelig J, Kröger N, Held TK et al. Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease. Haematologica 2002; 87: 299–305.

    PubMed  Google Scholar 

  10. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cyto-reduction for the treatment of malignant and non-malignant hematologic diseases. Blood 1998; 91: 756–763.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Schering Plough, Schering España, Merck Sharp and Dohme and Roche for their technical support.

Author information

Authors and Affiliations

  1. Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain

    M Subirà, A Sureda, I Ancín, R Martino, A Altés, S Brunet & J Sierra

Authors
  1. M Subirà
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Sureda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I Ancín
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Altés
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Brunet
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Sierra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Subirà.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Subirà, M., Sureda, A., Ancín, I. et al. Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure. Bone Marrow Transplant 32, 869–872 (2003). https://doi.org/10.1038/sj.bmt.1704254

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704254

Keywords

This article is cited by

Search

Advanced search

Quick links